MedPath
HSA Approval

Rabeprazole Sandoz Gastro Resistant Tablet 20mg

SIN14319P

Rabeprazole Sandoz Gastro Resistant Tablet 20mg

Rabeprazole Sandoz Gastro Resistant Tablet 20mg

March 8, 2013

NOVARTIS (SINGAPORE) PTE LTD

SANDOZ SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVARTIS (SINGAPORE) PTE LTD
Licence HolderSANDOZ SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, ENTERIC COATED

ORAL

Medical Information

A02BC04

rabeprazole

Manufacturer Information

SANDOZ SINGAPORE PTE. LTD.

Lek Pharmaceuticals d.d.

Lek Pharmaceuticals d.d. Lendava (Primary and Secondary Packager)

Active Ingredients

Rabeprazole 18.85mg eqv Rabeprazole Sodium

20mg

Rabeprazole

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Rabeprazole Sandoz Gastro Resistant Tablet 20mg - HSA Approval | MedPath